{{Drugbox
| Watchedfields = changed
| verifiedrevid = 447990763
| IUPAC_name = 2-(dimethylamino)ethyl 2-ethoxy-2,2-diphenylacetate
| image = Dimenoxadol.svg
| width = 180

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = S9
| legal_CA = Schedule I
| legal_UK =  
| legal_US = Schedule I
| legal_DE = Anlage I
| legal_UN = P I
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 509-78-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 17036
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01461
| ChEMBL = 2104309
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 16137
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4D65PBX0VK

<!--Chemical data-->
| C=20 | H=25 | N=1 | O=3 
| molecular_weight = 327.42 g/mol
| smiles = Cl.CCOC(C(=O)OCCN(C)C)(c1ccccc1)c1ccccc1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H25NO3/c1-4-24-20(17-11-7-5-8-12-17,18-13-9-6-10-14-18)19(22)23-16-15-21(2)3/h5-14H,4,15-16H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RHUWRJWFHUKVED-UHFFFAOYSA-N
| synonyms = Dimenoxadol, Estocin
}}

'''Dimenoxadol''' ([[International Nonproprietary Name|INN]]) (brand name '''Estocin''' (in [[Russia]])), or '''dimenoxadole''' ([[British Approved Name|BAN]]), is an [[opioid]] [[analgesic]] which is a [[benzilic acid]] derivative, closely related to [[benactyzine]] (an [[anticholinergic]]). Further, the structure is similar to [[methadone]] and related compounds like [[dextropropoxyphene]].

It was invented in Germany in the 1950s,<ref>{{cite patent | country = GB | number = 716700 | title = A new and improved analgesic and process for its production | inventor = Boehringer, A et al. | pubdate = 10/13/1954}}</ref> and produces similar effects to other opioids, including [[analgesia]], [[sedation]], [[dizziness]] and [[nausea]].<ref>{{Cite journal 
| last1 = Gorbatova | first1 = E. N. 
| title = The pharmacology of estocin, an new analgesic 
| journal = Stomatologiia 
| volume = 46 
| issue = 2 
| pages = 22–25 
| year = 1967 
| pmid = 5232927
}}</ref><ref>{{Cite journal 
| last1 = Kingisepp | first1 = G. A. 
| last2 = Kurvits | first2 = K. 
| last3 = Nurmand | first3 = L. B. 
| title = Pharmacology of dimethylaminoethyl ester of diphenylethoxyacetic acid hydrochloride--estocin 
| journal = Farmakologiia i toksikologiia 
| volume = 32 
| issue = 6 
| pages = 710–712 
| year = 1969 
| pmid = 5381602
}}</ref><ref>{{Cite journal 
| last1 = Liberman | first1 = S. S. 
| title = Analgesic action of estocin (dimethylaminoethyl ester hydrochloride of alpha, alpha-diphenylethoxyacetic acid) 
| journal = Farmakologiia i toksikologiia 
| volume = 31 
| issue = 6 
| pages = 668–671 
| year = 1968 
| pmid = 5729519
}}</ref>

In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9617 and a 2013 annual aggregrate manufacturing quota of zero.

== References ==
{{Reflist|2}}


{{Analgesics}}
{{Opioidergics}}

[[Category:Analgesics]]
[[Category:Synthetic opioids]]
[[Category:Ethers]]
[[Category:Carboxylate esters]]
[[Category:Mu-opioid agonists]]


{{analgesic-stub}}